CNS pipeline · person
Michael Cola, BA, MS
Chief Executive Officer of Cybin/Helus Pharma, appointed February 2026. More than 30 years of experience across neuroscience, rare disease and specialty pharmaceuticals; former President of Shire's Specialty Pharmaceutical business and former President and CEO of Avalo Therapeutics. Holds a BA in Biology from Ursinus College and an MS in Biomedical Science & Engineering from Drexel University.
- 1 company
Courtesy Cybin
Current roles
- Helus PharmaChief Executive Officer · Executive2026–present
Appears with
People sharing a company with Michael.
- Aaron Bartlone · Helus Pharma
- Alex Nivorozhkin · Helus Pharma
- Amir Inamdar · Helus Pharma
- Andrew J. Cutler · Helus Pharma
- Eric Hoskins · Helus Pharma
- Eric So · Helus Pharma
- Freda Lewis-Hall · Helus Pharma
- Gabe Fahel · Helus Pharma
- George Tziras · Helus Pharma
- Grant Froese · Helus Pharma
- Greg Cavers · Helus Pharma
- John Kanakis · Helus Pharma
- Lori Challenger · Helus Pharma
- Mark Lawson · Helus Pharma
- Maurizio Fava · Helus Pharma
- Paul Glavine · Helus Pharma
- Robert Langer · Helus Pharma
- Sanford R. Climan · Helus Pharma
- Sherri M. Altshuler · Helus Pharma
- Steve Brannan · Helus Pharma
- Theresa Firestone · Helus Pharma
- Thomas Laughren · Helus Pharma
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.